Mark Chandy
Impact in
- Molecular Biology top 10%
- Genomics and Chromatin Dynamics
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- Protein Degradation and Inhibitors
- Fungal and yeast genetics research
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- Chromatin Remodeling and Cancer
Papers in
-
- Genomics and Chromatin Dynamics 5
- Protein Degradation and Inhibitors 3
- Congenital heart defects research 3
- Pluripotent Stem Cells Research 3
- Co-authors
- Jerry L. Workman (6 shared papers)Michael J. Carrozza (2 shared papers)Philippe Prochasson (2 shared papers)Joseph C. Wu (9 shared papers)Kristen E. Neely (1 shared paper)Ahmed H. Hassan (1 shared paper)Scott Galasinski (1 shared paper)David T. Paik (3 shared papers)
- Journals
- Annual Review of Medicine (1 paper)Current Opinion in Lipidology (1 paper)Clinical Science (1 paper)EMBO Molecular Medicine (1 paper)Trends in Cardiovascular Medicine (1 paper)
- Partner nations
- United StatesCanadaSouth Korea
In The Last Decade
Mark Chandy
27 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 950
- Aging 6
- Plant Science 113
- Virology 14
- Cancer Research 41
Countries citing papers authored by Mark Chandy
This map shows the geographic impact of Mark Chandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Chandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Chandy more than expected).
Fields of papers citing papers by Mark Chandy
This network shows the impact of papers produced by Mark Chandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Chandy. The network helps show where Mark Chandy may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Chandy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 400 | |
| 2 | 2004 | 198 | |
| 3 | 2019 | 137 | |
| 4 | 2006 | 73 | |
| 5 | 2007 | 70 | |
| 6 | 2004 | 59 | |
| 7 | 2021 | 41 | |
| 8 | 2016 | 24 | |
| 9 | 2022 | 22 | |
| 10 | 2021 | 19 | |
| 11 | 2000 | 16 | |
| 12 | 2021 | 15 | |
| 13 | 2013 | 14 | |
| 14 | 2018 | 10 | |
| 15 | 2023 | 10 | |
| 16 | 2025 | 9 | |
| 17 | 2023 | 9 | |
| 18 | The Smoking Paradox: A Twist in the Tale of Vasospastic Angina. | 2021 | 6 |
| 19 | 2016 | 5 | |
| 20 | 2005 | 3 |
About Mark Chandy
Mark Chandy is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Pharmacology, Cellular and Molecular Neuroscience and Surgery, having authored 27 papers that have together received 1.1k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (5 papers), Protein Degradation and Inhibitors (3 papers), Cannabis and Cannabinoid Research (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Congenital heart defects research (3 papers), Pluripotent Stem Cells Research (3 papers), MicroRNA in disease regulation (2 papers) and Tissue Engineering and Regenerative Medicine (2 papers). The work is most often cited by research in Molecular Biology (950 citations), Aging (6 citations), Plant Science (113 citations), Virology (14 citations) and Cancer Research (41 citations). Mark Chandy has collaborated with scholars based in United States, Canada and South Korea. Frequent co-authors include Jerry L. Workman, Michael J. Carrozza, Philippe Prochasson, Joseph C. Wu, Kristen E. Neely, Ahmed H. Hassan, Scott Galasinski, David T. Paik, José L. Gutiérrez and Nicola J. Rinaldi. Their work appears in journals such as Annual Review of Medicine, Current Opinion in Lipidology, Clinical Science, EMBO Molecular Medicine and Trends in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.